--- title: "Tenaya Therapeutics gets Nasdaq notice for trading below $1.00" url: "https://aibio.space/news/tenaya-therapeutics-gets-nasdaq-notice-trading-below-1-00/" publisher: "aibio.space (Biotech Investor Relations News)" date: "2025-04-18" section: "Listings" tickers: "NASDAQ:TNYA" source: "https://www.sec.gov/Archives/edgar/data/1858848/000095017025055927/tnya-20250415.htm" summary: "Tenaya has until October 13, 2025 to regain compliance, and may get another 180 days if it moves to the Nasdaq Capital Market." --- By the aibio.space news desk. Sources - [Tenaya Therapeutics, Inc. 8-K (2025-04-18)](https://www.sec.gov/Archives/edgar/data/1858848/000095017025055927/tnya-20250415.htm) [TNYA](https://aibio.space/companies/tenaya-therapeutics/) 2025-04-18 # Tenaya Therapeutics gets Nasdaq notice for trading below $1.00 Tickers [TNYA](https://aibio.space/companies/tenaya-therapeutics/) Tenaya has until October 13, 2025 to regain compliance, and may get another 180 days if it moves to the Nasdaq Capital Market. ## Key facts - **Company**: Tenaya Therapeutics, Inc. (NASDAQ: TNYA) - **News type**: Listings - **Primary source**: [Tenaya Therapeutics, Inc. 8-K (2025-04-18)](https://www.sec.gov/Archives/edgar/data/1858848/000095017025055927/tnya-20250415.htm) *The White House and its lawn. CC0, via rawpixel. The picture shows the field, not the companies named.* Tenaya Therapeutics, Inc. said it received a letter on April 15, 2025 from the Listing Qualifications Staff of The Nasdaq Stock Market LLC. The letter said the company did not meet the minimum bid price of $1.00 per share required for continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1). This is a bid price deficiency. Nasdaq based it on the closing bid price of Tenaya's common stock for the 30 consecutive business day period between March 3, 2025, through April 12, 2025. Tenaya has a compliance period of 180 calendar days, or until October 13, 2025, under Nasdaq Listing Rule 5810(c)(3)(A). To regain compliance, the stock must close at or above $1.00 for at least ten consecutive business days in that period. The letter has no immediate impact on the listing. If Tenaya misses the deadline, it may be eligible for an additional 180 calendar days by transferring to the Nasdaq Capital Market. It would need to submit a transfer application, pay a fee and meet the other listing standards except the bid price rule. It would also need to give written notice that it intends to cure the deficiency, by a reverse stock split if necessary. The company said it intends to monitor its closing bid price and "may, if appropriate, evaluate available options to resolve the deficiency." It said there can be no assurance it will regain compliance. The notice is in the company's [8-K filing](https://www.sec.gov/Archives/edgar/data/1858848/000095017025055927/tnya-20250415.htm). [Report an error](https://aibio.space/reputation/#correction) ## Companies in this story TNYA Tenaya Therapeutics, Inc. NASDAQ ยท United States Open the starter desk ## More in Listings Listings ### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/) Oct 29, 2026 Listings ### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/) Oct 29, 2026 Listings ### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/) Oct 28, 2026 --- Source page: https://aibio.space/news/tenaya-therapeutics-gets-nasdaq-notice-trading-below-1-00/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Tenaya Therapeutics gets Nasdaq notice for trading below $1.00", 2025-04-18, https://aibio.space/news/tenaya-therapeutics-gets-nasdaq-notice-trading-below-1-00/